Zini G, Bellesi S, Ramundo F, D’Onofrio G. Morphological anomalies of circulating blood cells in COVID-19. Am J Hematol. 2020;95:870-872. https://doi.org/10.1002/ajh.25824
Sadigh S, Massoth LR, Christensen BB, Stefely JA, Keefe J, Sohani AR. Peripheral blood morphologic findings in patients with COVID-19. Int J Lab Hematol. 2020;42:e248-e251. https://doi.org/10.1111/ijlh.13300
Foldes D, Hinton R, Arami S, Bain BJ. Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19). Am J Hematol. 2020;95:861-862. https://doi.org/10.1002/ajh.25834
Ljungman P, Mikulska M, de la Camara R, et al. The challenge of COVID-19 and hematopoietic cell transplantation. EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. Bone Marrow Transplant. 2020;55:2071-2076. https://doi.org/10.1038/s41409-020-0919-0
Khan AM, Ajmal Z, Raval M, Tobin E. Concurrent diagnosis of acute myeloid leukemia and COVID-19: a management challenge. Cureus. 2020;12:4-5. https://doi.org/10.7759/cureus.9629
Paul S, Rausch CR, Jain N, et al. Treating leukemia in the time of COVID-19. Acta Haematol. 2020;77030. https://doi.org/10.1159/000508199
Ferrara F, Zappasodi P, Roncoroni E, Borlenghi E, Rossi G. Impact of Covid-19 on the treatment of acute myeloid leukemia. Leukemia. 2020;34:2254-2256. https://doi.org/10.1038/s41375-020-0925-7
Malard F, Genthon A, Brissot E, et al. COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplant. 2020;55:2180-2184. https://doi.org/10.1038/s41409-020-0931-4
